Gestione del diabete nel paziente oncologico

作者: Marco Gallo , Sara Belcastro

DOI: 10.1007/S40619-018-0455-Y

关键词: HumanitiesMedicine

摘要: Chi e affetto da diabete mellito ha un rischio aumentato di ammalarsi cancro viceversa: l’iperglicemia, infatti, puo manifestarsi in malato oncologico sia come effetto indiretto dei trattamenti antitumorali conseguenza diretta del tumore, conferendo piu elevato esito sfavorevole mortalita. In considerazione della complessita condizione clinica, necessaria una stretta cooperazione tra tutte le figure specialistiche coinvolte a vario titolo nell’assistenza al paziente, fine garantire approccio diagnostico-terapeutico il appropriato ed efficace possibile.

参考文章(10)
Amy Calabrese Donihi, Ditina Raval, Melissa Saul, Mary T. Korytkowski, Michael A. DeVita, PREVALENCE AND PREDICTORS OF CORTICOSTEROID-RELATED HYPERGLYCEMIA IN HOSPITALIZED PATIENTS Endocrine Practice. ,vol. 12, pp. 358- 362 ,(2006) , 10.4158/EP.12.4.358
G. Ariaans, S. de Jong, J.A. Gietema, J.D. Lefrandt, E.G.E. de Vries, M. Jalving, Cancer-drug induced insulin resistance: innocent bystander or unusual suspect. Cancer Treatment Reviews. ,vol. 41, pp. 376- 384 ,(2015) , 10.1016/J.CTRV.2015.02.007
P. Jacob, T.A. Chowdhury, Management of diabetes in patients with cancer. QJM: An International Journal of Medicine. ,vol. 108, pp. 443- 448 ,(2015) , 10.1093/QJMED/HCU218
Mario Sznol, Harriet Kluger, Kevan C. Herold, Scott Gettinger, Nalini Vudattu, Beatrice Lupsa, Jing Hughes, Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. Diabetes Care. ,vol. 38, ,(2015) , 10.2337/DC14-2349
P. Vigneri, F. Frasca, L. Sciacca, L. Frittitta, R. Vigneri, Obesity and cancer. Nutrition Metabolism and Cardiovascular Diseases. ,vol. 16, pp. 1- 7 ,(2006) , 10.1016/J.NUMECD.2005.10.013
H. M. Psarakis, Clinical Challenges in Caring for Patients With Diabetes and Cancer Diabetes Spectrum. ,vol. 19, pp. 157- 162 ,(2006) , 10.2337/DIASPECT.19.3.157
Bruno Vergès, Thomas Walter, Bertrand Cariou, ENDOCRINE SIDE EFFECTS OF ANTI-CANCER DRUGS: Effects of anti-cancer targeted therapies on lipid and glucose metabolism European Journal of Endocrinology. ,vol. 170, ,(2014) , 10.1530/EJE-13-0586
Marco Gallo, Luigi Gentile, Emanuela Arvat, Oscar Bertetto, Gennaro Clemente, Diabetology and oncology meet in a network model: union is strength. Acta Diabetologica. ,vol. 53, pp. 515- 524 ,(2016) , 10.1007/S00592-016-0839-Z
Marco Gallo, Giovanna Muscogiuri, Francesco Felicetti, Antongiulio Faggiano, Francesco Trimarchi, Emanuela Arvat, Riccardo Vigneri, Annamaria Colao, Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes. Metabolism-clinical and Experimental. ,vol. 78, pp. 141- 154 ,(2018) , 10.1016/J.METABOL.2017.09.013